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CpG binding protein (CFP1) occupies 
open chromatin regions of active genes, 
including enhancers and non-CpG islands
Louie N. van de Lagemaat1 , Maria Flenley2, Magnus D. Lynch2,3,7, David Garrick4, Simon R. Tomlinson5, 
Kamil R. Kranc5,6 and Douglas Vernimmen1* 
Abstract 
Background: The mechanism by which protein complexes interact to regulate the deposition of post-translational 
modifications of histones remains poorly understood. This is particularly important at regulatory regions, such as CpG 
islands (CGIs), which are known to recruit Trithorax (TrxG) and Polycomb group proteins. The CxxC zinc finger protein 
1 (CFP1, also known as CGBP) is a subunit of the TrxG SET1 protein complex, a major catalyst of trimethylation of H3K4 
(H3K4me3).
Results: Here, we used ChIP followed by high-throughput sequencing (ChIP-seq) to analyse genomic occupancy 
of CFP1 in two human haematopoietic cell types. We demonstrate that CFP1 occupies CGIs associated with active 
transcription start sites (TSSs), and is mutually exclusive with H3K27 trimethylation (H3K27me3), a marker of polycomb 
repressive complex 2. Strikingly, rather than being restricted to active CGI TSSs, CFP1 also occupies a substantial frac-
tion of active non-CGI TSSs and enhancers of transcribed genes. However, relative to other TrxG subunits, CFP1 was 
specialised to TSSs. Finally, we found enrichment of CpG-containing DNA motifs in CFP1 peaks at CGI promoters.
Conclusions: We found that CFP1 is not solely recruited to CpG islands as it was originally defined, but also other 
regions including non-CpG island promoters and enhancers.
Keywords: CFP1, CpG islands, Trithorax group proteins, Epigenetics, Enhancers
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Background
In vertebrate genomes, CpG dinucleotides are relatively 
depleted, except in specific DNA regions with a high den-
sity of this dinucleotide. These regions are known as CpG 
islands (CGIs) and consist of short (~ 1000  bp) inter-
spersed CpG-rich and predominantly unmethylated DNA 
sequences [1], which are associated with transcriptionally 
permissive chromatin state [2]. Interestingly, the human 
genome harbours roughly twofold more annotated CGIs 
than the mouse genome (27,000 versus 15,000) [3]. CGIs 
were originally identified in promoters of housekeeping 
genes and associated with H3K4me3 independent of gene 
activity [1]. However, it is now recognised that CGIs are 
also found in about half the promoters of developmen-
tally regulated/tissue-specific genes [4]. In this group of 
CGIs, repressive polycomb group (PcG) complexes act to 
block transcription in inappropriate lineages or at non-
expressing stages during the differentiation programme. 
It has been hypothesised that CGIs at developmentally 
regulated genes of higher organisms may be relics of 
ancestral CGIs which have been differentially maintained 
during evolution, for example, in humans and rodents 
[3–8]. Thus, at present, the functional significance of 
these CGIs for the correct regulation of developmentally 
regulated genes is poorly understood. A good example of 
this is the well-studied α-globin locus. Mouse α-globin 
genes, which lack an annotated CGI, exhibit tightly regu-
lated tissue and developmental stage-specific regulation 
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similar to that observed for the human α-globin genes, 
which contain a CGI and are regulated by PcG [9].
Several proteins have been described in mammals 
that bind specifically to CGIs. These proteins contain 
the CxxC zinc finger (ZF-CxxC) domain and include 
CFP1, MLL1, MLL2, KDM2A, KDM2B, TET1 and 
TET3 [10]. Whilst MLL1/2 also have inherent histone 
lysine N-methyltransferase activity, CFP1 does not, 
instead forming complexes with SET1A and SET1B 
methyltransferases, TrxG subunits of the SET1 family 
[11]. CFP1-SET1A/B complexes have been implicated 
in development [11, 12] and are known to target a pro-
portion of H3K4 methylation to CGIs [12, 13]. CFP1 
binds unmethylated CpG-rich sequence [14], and is 
associated with H3K4 trimethylation at transcription 
start sites (TSSs) irrespective of transcription level [15, 
16], although recent evidence showed that it preferen-
tially binds CGIs of actively transcribed genes [17]. Two 
other TrxG complexes, MLL3 and MLL4, lack ZF-CxxC 
domains [10] and have been suggested to be involved in 
deposition of H3K4me1 at enhancer elements [18–20].
Multiple phenotypes have been documented for CFP1 
deficiency, both at the cellular and organismal level. 
CFP1 is required for development [21], differentiation 
of embryonic stem (ES) cells [22] and haematopoiesis 
[23–25]. CFP1 binds to unmethylated CGIs in mouse ES 
cells [15, 17] and mouse brain tissues [16], and knockout 
and knockdown of CFP1 in mouse ES cells and NIH3T3 
fibroblasts result in reduction of H3K4me3 levels at CGIs 
[16, 17]. Mouse ES cells lacking CFP1 are viable but are 
unable to differentiate [22, 26]. In these cells, H3K4me3 
was found to be mainly reduced at highly expressed 
genes, while the levels at other CGIs such as bivalent 
domains were largely unchanged [15]. These observa-
tions may be explained by the above-mentioned CFP1 
preference for actively transcribed genes and the find-
ing that MLL2 (rather than SET1) complexes are largely 
responsible for initial deposition of H3K4me3 at bivalent 
domains [27, 28].
Here we have analysed the genome-wide occupancy of 
CFP1 in two divergent human haematopoietic cell types: 
erythroid (ERY) and EBV-transformed B-lymphoid 
(EBV) cells. Previous studies using chromatin immuno-
precipitation (ChIP) have been restricted to a couple of 
available antibodies with moderate signal, which con-
sequently limited the sensitivity of the analysis [15, 29]. 
Here, using a non-commercial, high-affinity antibody 
[30], our analysis reveals that the presence of CFP1 at 
accessible CGI TSSs is associated with Pol II binding and 
gene expression. Moreover, H3K27me3, which is a mark 
of PcG (PRC2) activity, and binding of CFP1 are mutually 
exclusive at TSSs. Unexpectedly, CFP1 is also recruited 
to a substantial fraction of non-CGI-associated TSSs 
and active enhancer elements. In comparison with other 
TrxG complex subunits, CFP1 is specialised to active 
TSSs. Finally, our analysis revealed enrichment of CpG 
dinucleotide-containing motifs in CFP1 peaks at CGIs.
Results
CFP1 primarily binds at active CGI TSSs and is associated 
with transcription
We previously reported an association of CFP1 binding 
with transcription at the α-globin locus, using a mouse 
model in which the mouse α-globin locus was replaced 
by the human locus [29, 31]. In this “humanised” mouse 
model, the epigenetic regulation of the human locus in 
mouse erythroblasts mirrors that observed in human pri-
mary erythroblasts, including recruitment of PcG when 
the gene is silenced [29]. In these humanised mouse 
erythroid cells, the targeted deletion of a key human 
α-globin enhancer (MCS-R2, also known as HS-40) 
results in a strong reduction in α-globin transcription 
[31, 32]. This is associated with the maintenance of PcG 
binding [29] and an impairment of CFP1 recruitment to 
the human α-globin promoter [29]. Similarly, in human 
primary erythroid and lymphoid (EBV-transformed) cell 
types, where this locus is active and inactive, respectively, 
CFP1 is recruited to the CGI spanning the α-globin gene 
only in erythroid cells [29]. Experiments with a robust, 
non-commercial CFP1 antibody [30] confirmed these 
results in primary cells (Additional file  1: Fig. S1A) and 
in the humanised mouse model (Additional file  1: Fig. 
S1B). ChIP signals derived from this antibody were sev-
eral fold stronger than a comparable commercial CFP1 
antibody (Additional file 1: Fig. S1C). The non-commer-
cial antibody was tenfold more sensitive (14,872 peaks, 
as described below, versus 1434 in erythroid cells), and 
in 1102 locations where the peaks overlapped it showed 
a median 2.3 fold higher enrichment of reads in peaks 
given a similar number of ChIP-seq reads and the same 
input data. Given this tenfold greater sensitivity and 2.3-
fold greater specificity, it was the primary antibody used 
in this study.
To identify genomic regions recruiting CFP1, we per-
formed ChIP-seq in primary human lymphoid and 
erythroid cell types (biological replicates from Fig. S1A, 
Additional file  1). As shown in Fig.  1a, heatmaps of 
genomic TSSs and CGIs showed that these regions were 
strongly enriched in CFP1 binding. As shown in Fig. 1b, 
genomic CFP1 localisation was remarkably similar in 
both cell types, with a large number of peaks located at 
TSSs with annotated CGIs: 62.2% (9251/14,872) and 
42.5% (9055/21,301) of genome-wide CFP1 summits 
were associated with CGI promoters in erythroid and 
lymphoid cells, respectively. Amongst non-CGI genomic 
regions of CFP1 binding, TSSs were less prominent 
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(Fig.  1b). As shown in Fig. S1D (Additional file  1), CGI 
and non-CGI TSSs differed strongly in CpG content 
within a 1-kb window centred on TSSs. CpG content of 
representative CGI and non-CGI loci considered hereaf-
ter are graphed in Fig. S1D (Additional file 1) .
As shown in Fig. 1a, CFP1-bound TSSs were depleted 
in H3K27me3 and H3K4me1 histone marks, whilst 
being strongly enriched in H3K4me3. The association 
between CFP1 and H3K4me3 could either reflect depo-
sition of H3K4me3 by CFP1-SET1A/B complexes, or 
binding to pre-existing H3K4me3, deposited by other 
TrxG complexes [33], through the PHD finger domain 
of CFP1 [17]. Accordingly, we found strong association 
between peaks of CFP1 and H3K4me3 in both erythroid 
and lymphoid cell types, both qualitatively at the level of 
heatmaps (Fig.  1a) and quantitatively in peak overlaps 
(Fig. 1c). Indeed, the fraction of CFP1 peaks overlapped 
with H3K4me3 was nearly 100% when the alternate peak 
finder, MACS2, was used (Additional file 1: Fig. S2).
In contrast to H3K4me3 and CFP1, little if any colo-
calisation was observed between CFP1 and H3K27me3. 
To further characterise depletion of H3K27me3 (a his-
tone mark associated with PcG binding) in CFP1-bound 
regions, we plotted averaged read depth in a 2-kb window 
surrounding TSSs for CFP1 versus H3K27me3. As shown 
in Fig.  1d, TSSs showed mutual exclusivity between 
H3K27me3 and CFP1 occupancy, with marked prefer-
ence for binding of either CFP1 or PRC2 (H3K27me3), 
or neither, but not both; this was observed consist-
ently in erythroid and lymphoid cell types. This result 
demonstrates that mutual exclusivity of CFP1 and the 
H3K27me3 mark at TSSs, which was first described in 
the α-globin locus [29], is a general genome-wide mecha-
nism in disparate cell types.
Binding of CFP1 to housekeeping and tissue‑specific gene 
TSSs
We next assessed CFP1 occupancy at TSSs by gene class, 
specifically housekeeping genes and developmentally 
regulated/tissue-specific genes (Fig.  2 and Additional 
file  1: Fig. S3). Both the α-globin locus in erythroblasts 
(Fig.  2a, left) and IRF4 locus in lymphoid cells (Fig.  2a, 
right) exhibit lineage-specific binding of CFP1. House-
keeping genes such as ACTB and LUC7L (located just 
downstream of the α-globin locus) showed binding in 
both cell types (Fig. 2b). The CGI promoter of RHBDF1, 
which is not expressed in either cell type, was marked by 
H3K27me3 in both erythroid and lymphoid cell types 
(Additional file 1: Fig. S3C), but was not bound by CFP1 
(Fig. 2c).
We then extended our analysis to genome-wide sets of 
housekeeping and developmentally regulated/tissue-spe-
cific genes. First, we used the Illumina Body Map RNA-
seq data set of 16 human tissues to identify 5354 genes 
with similar expression across most or all of these tis-
sues and termed these housekeeping genes (Fig.  2d; see 
“Methods”). Another 7150 genes with low expression in 
nine or more of 16 tissues were termed candidate tissue-
specific genes. RNA-seq data sets from erythroblasts and 
EBV-transformed lymphoid cells were then used to iden-
tify candidate tissue-specific genes with elevated expres-
sion in these cell types (412 genes in erythroid and 658 
in lymphoid cells; see “Methods”). Interestingly, CXXC1 
mRNA, which encodes CFP1 protein, was denominated a 
housekeeping gene, with mean RPKM (reads per kilobase 
of transcript per million mapped reads) of 5.8 (± 3.1 SD). 
Public expression data sets for EBV and ERY cells showed 
overexpression of CXXC1 in EBV (RPKM = 50.6) and 
reduced expression in ERY (RPKM = 0.62). This mRNA 
expression difference corresponded to approximately 
twofold higher expression at the protein level in lym-
phoid cells (Additional file 1: Fig. S4).
To address the confounding effect of alternate TSSs of 
transcribed genes, some with or without CGIs, and some 
transcribed or not, we next limited our analysis to puta-
tively expressed TSSs. These were identified by accessible 
chromatin, which was defined by the presence of 1x-nor-
malised/input-subtracted ATAC (Assay for Transposase-
Accessible Chromatin) signal > 10 within 1 kb of the TSS. 
Most putatively expressed TSSs regardless of gene class 
were marked by CGIs (defined by a distance < 1 kb; green 
dotted lines, Fig.  2d). However, a larger proportion of 
housekeeping gene TSSs were marked by a CGI (94.7% 
in erythroid and 96.8% in lymphoid cells), compared to 
(See figure on next page.)
Fig. 1 Genomic distribution of CFP1 relative to CpG islands, transcription start sites (TSSs) and marks of active and repressed chromatin. a 
Heatmap plots of human genomic 6-kb regions centred on TSSs (top) and CGIs (bottom) in erythroblasts (ERY) and Epstein-Barr virus transformed 
lymphoblast (EBV) cells. TSSs sorted in order of CFP1 coverage; CGIs sorted in order of size. Sequencing read depths shown for CFP1, H3K27me3, 
H3K27ac, H3K4me1, H3K4me3, DNase-seq, ATAC-seq and Pol II are net coverage after normalisation to 1x genome-wide and subtraction of an input 
data set similarly normalised. Gene expression  (log2 RPKM) is shown to the right for TSSs in both cell types. b Location of CFP1 summits allocated 
in order of CGI TSS (< 1 kb), CGI genic, CGI intergenic, (non-CGI) TSS (< 1 kb), (non-CGI) genic and (non-CGI) intergenic. ERY, top; and EBV, bottom. c 
Venn diagrams showing CFP1 peaks within 1-kb of TSSs are strongly associated with H3K4me3 histone mark and poorly associated with H3K27me3 
repressive histone mark. Cell types are ERY (upper) and EBV (lower). Public data sets: * NCBI GEO GSE36985, ** NCBI GEO GSE50893. d Mutual 
exclusivity of CFP1 and the H3K27me3 mark in ERY (upper) and EBV (lower) cell types
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TSSs of tissue-specific genes (77.5% in erythroid and 
82.5% in lymphoid cells). CGIs accounted for most of 
the CFP1 occupancy at TSSs, an observation recapitu-
lated in both gene classes and both cell types, and CFP1 
peaks were biased for CGI TSSs in all gene classes, as 
expected (OR ≥ 5.9, p ≤ 1.6 × 10−12, Additional file  1: 
Table S1). Notably, though, housekeeping genes showed 
increased frequency of CFP1 peaks compared to tissue-
specific genes, and this was true in both cell types in 
both CGI and non-CGI TSSs (Additional file 1: Table S2). 
Taken together, these findings reinforce the observa-
tion that CFP1 occupancy marks active CpG-rich TSSs 
of both housekeeping and tissue-specific genes, but also 
reveal that CFP1 is preferentially associated with TSSs of 
broadly expressed genes whether or not they meet strict 
criteria for housekeeping genes (see “Methods”).
CFP1 binds to non‑CGI regions associated 
with transcription
Remarkably, although we observed significant CFP1 
bias for CGI TSSs, our data also revealed that CFP1 
was bound to a proportion of accessible non-CGI TSSs: 
for example, 36/78 (46%) and 7/44 (16%) tissue-specific 
TSSs in ERY and EBV, respectively (Fig. 2d). More than 
half of non-CGI housekeeping TSSs were occupied by 
CFP1, consisting of 214/335 (64%) TSSs in ERY and 
84/139 (60%) TSSs in EBV (Fig.  2d). In addition to 
expressed non-CGI TSSs, we found the vast majority 
a
b c
d e
Fig. 2 CFP1 localisation in TSSs of housekeeping and tissue-specific genes in ERY and EBV cell types. a–c CFP1 binding specifically to TSSs in ERY 
(upper) and EBV (lower) cell types. Chromosomal position specified in the human hg38 genome build. Pileups are shown scaled to 1x genome 
coverage, with full scale 0–200x depth. a Tissue-specifically expressed loci: α-globin (chr16, left, expressed in ERY) and IRF4 (chr6, right, expressed 
in EBV). b Housekeeping genes: ACTB (chr7, left) and LUC7L (chr16, right). c RHBDF1 locus (chr16) with CGI promoter, but not transcribed in ERY or 
EBV. d Upper circles show counts of tissue-specific ERY-expressed (left), housekeeping (centre) and tissue-specific EBV lymphoid-expressed (right) 
genes, with total TSSs shown in parentheses. Lower pie charts show analysis of CFP1 ChIP peaks computed in accessible TSSs of ERY (red) and EBV 
(blue) cell types. Darker colours represent TSSs with CFP1 peaks, and dashed green lines indicate TSSs having a CGI. e CFP1 at two loci expressed in 
ERY: α-globin gene HBA1, expressed from a CGI TSS, compared to β-globin gene HBB, expressed from a non-CGI TSS
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of annotated, expressed CGI TSSs occupied by CFP1, 
including 233/269 (86%) tissue-specific and 5600/5948 
(94%) housekeeping TSSs in ERY. Low CpG density, 
however, was not necessarily correlated with a lack of 
CFP1 binding, as exemplified by the well-characterised 
β-globin gene HBB. The HBB locus is CpG-poor (Addi-
tional file  1: Fig. S1D), but shows similar CFP1 ChIP 
signal intensity in erythroid cells to that observed at 
α-globin gene promoters (Fig.  2e). Experiments using 
the previously described CFP1 antibody from Abcam 
confirmed these results, albeit with weaker ChIP signal 
(Additional file 1: Fig. S5). These findings call into ques-
tion the previously reported CGI specificity for this 
protein [14] and raise the possibility that the recruit-
ment of CFP1 at non-CGI sites may occur by protein–
protein interactions with pre-existing H3K4me3, due to 
the reader properties of the plant homeodomain (PHD) 
of CFP1 [17, 26, 33].
Coincident CFP1 and Pol II binding at accessible, expressed 
TSSs
We next examined more closely the relationship between 
CFP1, Pol II and expression level using public RNA-seq 
data sets. We limited our analysis to accessible TSSs 
(defined by overlap with a 1x-normalised, input-sub-
tracted ATAC-seq signal > 10); this accessibility makes 
these strong candidate TSSs for the observed expres-
sion (Fig.  3a, b). Accessible TSSs of expressed genes in 
both cell types were occupied with CFP1, regardless of 
the presence of a CGI (Fig. 3c–f). A few accessible TSSs 
appeared non-expressed in the available public eryth-
roid data set (GSE74246) while displaying some CFP1 
binding in our independent data set (bottom of Fig.  3c, 
d). We considered it most likely that these are small arte-
facts due to variability between RNA-seq data sets. Puta-
tively accessible, expressed TSSs were almost universally 
marked by Pol II (Fig. 3g–j); however, strength of Pol II 
Fig. 3 CFP1 binding in TSSs is predictive of expression from accessible TSSs. Upper panels (a, c, d, g, h, k, l) represent data in Erythroblasts (ERY) 
and lower panels (b, e, f, i, j, m, n) represent EBV-lymphoblasts (EBV). a, b Heatmap analysis of CFP1 binding. TSSs are divided into CGI and 
non-CGI subsets, and then ordered by expression RPKM values. CFP1 and Pol II are measured as read depth normalised to 1x genome-wide, and 
input-subtracted. c–f Gene expression level plotted against normalised CFP1 signal (thresholded and log-transformed). Gene expression measure 
is  log2 RPKM of all transcripts of the gene combined. c, e CGI TSSs and d, f non-CGI TSSs. g–j Gene expression level plotted against normalised Pol II 
signal. g, i CGI TSSs and h, j non-CGI TSSs. k–n Pol II signal plotted against CFP1 signal: k, m CGI TSSs and l, n non-CGI TSSs
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ChIP signals was only poorly correlated with expression, 
in line with the observations of others [34]. Plotting Pol II 
versus CFP1 occupancy at accessible TSSs (Fig. 3k–n), we 
found that TSSs with increased Pol II intensity also exhib-
ited generally increased CFP1 intensity. The correlation 
between Pol II and CFP1 intensity at these loci was weak 
in EBV cells (Pearson R = 0.28, p < 10−200, and R = 0.26, 
p = 1.4 × 10−12, in CGI and non-CGI TSSs, respectively); 
however, this correlation was visually identifiable in ERY 
(Pearson R = 0.61, p < 10−200, and R = 0.71, p < 10−200, in 
CGI and non-CGI TSSs, respectively). Within the limits 
of public data sets, these results demonstrate a weak pos-
itive relationship between Pol II and CFP1 at accessible, 
transcribed TSSs.
Occupancy of CFP1 at enhancers
Unmethylated CpG dinucleotides at TSSs are known to 
recruit CFP1 through its ZF-CxxC domain [14]. However, 
recent studies have demonstrated that, in addition, CFP1 
can bind all three H3K4 methylation states with varying 
affinity via its PHD zinc finger domain [17, 26, 33]. Fre-
quent localisation of H3K4me1 at enhancers could there-
fore predict the presence of CFP1 at enhancers.
To address localisation of CFP1 at enhancers, puta-
tive enhancers were defined by open chromatin (ATAC-
seq) and the presence of Pol II in non-TSS regions 
(Fig.  4a, see “Methods”). Elevated DNase hypersensitiv-
ity, strong bimodal H3K4me1 signal and H3K27ac sur-
rounding these loci confirmed that these sites are likely 
active regulatory regions. The presence of little or no 
H3K4me3 and separation from known TSSs rules out a 
role for these sites as alternative promoters. The elevated 
ATAC-seq signal in these regions was largely tissue spe-
cific, with 10,548 and 3956 putative enhancers identified 
in erythroid and lymphoid cells, respectively; only 480 
overlaps were observed between these sets of putative 
enhancers. It should be noted that these putative enhanc-
ers represent only a stringent subset with an arbitrarily 
high ATAC-seq signal, and thus they represent the best-
supported candidate enhancers based on the data sets 
available.
Elevated CFP1 signal was observed at putative enhanc-
ers in both cell types, and heatmap evidence suggested 
qualitative association between CFP1 and signatures 
of open chromatin (elevated ATAC-seq, DNase-seq, 
H3K27ac and H3K4me1 signals, Fig.  4a). Indeed, 
averaged in 2-kb windows around putative enhanc-
ers, putative enhancers with above-median ATAC-seq 
and DNase-seq signals showed elevated CFP1 signal 
(p < 10−200, t test, both cell types); this, however, was less 
intense than in accessible TSSs (Fig.  4b). Furthermore, 
the correlation of CFP1 signal with chromatin accessibil-
ity signals was poorer in enhancers than in TSSs for both 
cell types (Fig. 4a, c). Nonetheless, CFP1 signal intensity 
was high at putative enhancers associated with a CpG 
island. Furthermore, intergenic CFP1 peaks (Fig.  1b) 
showed strong, non-random overlap with our set of 
putative enhancers. In erythroid cells, 444/1673 CFP1 
peaks were colocalised with putative enhancers, which 
cover 0.16% of the genome (166-fold overrepresented, 
p < 10−200, binomial test); in lymphoid cells a weaker but 
specific overrepresentation was noted, with 159/5488 
intragenic CFP1 peaks colocalising with this stringently 
defined set of putative enhancers (18.1-fold overrepre-
sented, p = 1.5 × 10−137). These findings demonstrate the 
presence of CFP1 at enhancers and demonstrate that its 
association with enhancers is specific.
CFP1 colocalises with members of the SET1 complexes
The chromatin-binding properties of CFP1, aided by a 
SET1 subunit, anchor SET1A/B complexes in accessible 
chromatin [12, 13, 17, 26, 35], and these SET1A/B—along 
with other TrxG—complexes are responsible for H3K4 
methylation in accessible chromatin [13, 18–20, 27, 28, 
36–38]. To investigate this, we performed additional 
ChIP-seq experiments in erythroid cells. We examined 
genomic occupancies of SET1A (SETD1A) and Host Cell 
Factor 1 (HCF1/HCFC1), subunits of the SET1A com-
plexes (Fig.  5, Additional file  1: Fig. S6), and RBBP5, a 
core subunit of all TrxG complexes [11, 39].
To probe the composition of these complexes, we first 
asked to what extent observed peaks of CFP1, SET1A, 
HCF1 and RBBP5 were consistent with known compo-
sition of SET1A complexes. Upon examination of these 
ChIP peak overlaps within a high-confidence subset 
of peak regions (Fig.  5c, see “Methods”), three obser-
vations supported the concept that these proteins are 
subunits of the same complex. First, we observed strong 
colocalisation between SET1A and CFP1 such that 
92.9% (4266/4594) of SET1A peaks were colocalised 
with 59.4% of the 7179 CFP1 peaks (red outline, Fig. 5c). 
This observation is consistent with a role for CFP1 as a 
Fig. 4 CFP1 binding and histone methylation marks in putative enhancers and comparison to TSSs. a Loci sorted by H3K4me1 signal in 6-kb 
regions surrounding putative enhancers. Upper panels, ERY; lower, EBV. Note that all data sets, other than CFP1, differ by source between ERY and 
EBV, which explains prominent differences in signal intensities, for example, of H3K27ac and H3K4me1. b Quantitative comparison of signal intensity 
in TSSs and putative enhancers, above and below median accessibility (as determined by ATAC-seq data), with cell types indicated. c Plots of ChIP 
signals for erythroid (left) and lymphoid cells (right), in putative enhancers (lower left graphs) and TSSs (upper right graphs)
(See figure on next page.)
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subunit recruiting SET1A and other proteins to bind to 
DNA. Furthermore it is consistent with the known dif-
ference between SET1A and SET1B localisation [38]: 
excess CFP1 peaks likely are accounted for by SET1B 
complexes. Secondly, we noted that 90.9% (6528/7179) 
of CFP1 peaks were colocalised with RBBP5 (blue out-
line, Fig. 5c), which is known to form part of a catalytic 
ASH2L-RBBP5 heterodimer that activates methyltrans-
ferase activity in TrxG complexes [36]. This observation 
suggests a near-complete association of genome-bound 
CFP1 with RBBP5. Thirdly, we found that a large major-
ity (85.0%, 2047/2408) of HCF1 peaks were colocal-
ised with CFP1, SET1A and RBBP5 (bold font, Fig.  5c). 
This and the fact that HCF1 colocalisation accounted 
for a substantial fraction of these three other peak-sets 
is consistent with CFP1, HCF1 and RBBP5 being obli-
gate members of SET1A complexes. Taken together, 
this analysis shows that in regions of high-confidence 
ChIP signals: (1) there is intimate and specific associa-
tion between SET1A complex components; (2) genomic 
SET1A and HCF1 are largely or entirely colocalised with 
CFP1; and (3) the vast majority of genome-bound CFP1 
is associated with RBBP5.
CFP1‑SET1A complexes are specialised to TSSs relative 
to other TrxG complexes
Notably, the above analysis of SET1A complex subunits 
showed that RBBP5 had a small but substantial fraction 
of remaining peaks not colocalised with these subunits, 
suggestive of additional genomic roles for this protein. 
Therefore, in an expanded analysis, we considered colo-
calised SET1A and CFP1 (CFP1-SET1A) as representa-
tive of SET1A complexes, Menin as a representative 
of MLL1/2 complexes and UTX as a representative of 
MLL3/4 complexes (Additional file 1: Fig. S7). This analy-
sis demonstrated that the excess of RBBP5 peak regions 
unaccounted for by CFP1-SET1A was accounted for by 
representatives of the MLL1/2 and MLL3/4 complexes. 
It also showed that genomic occupancy of HCF1 was 
almost completely accounted for by overlaps with CFP1-
SET1A and Menin, which are representatives of SET1 
and MLL1/2, respectively. These observations support 
the view that CFP1, SET1A, HCF1, Menin, UTX and 
RBBP5 represent a set of proteins whose subunit interac-
tions define compositionally distinct complexes that nev-
ertheless overlap in their genomic occupancy.
We next asked if genomic occupancy of CFP1-SET1A 
complexes was specialised relative to other TrxG com-
plexes. Specifically, we hypothesised that CFP1-SET1A 
complexes could differ from other TrxG complexes in 
their localisation to genomic TSSs and putative enhanc-
ers defined earlier. Removing from consideration the 
small numbers of exclusive CFP1-SET1A (n = 9), Menin 
(n = 583) and UTX (n = 507) peak regions not colocalis-
ing with other TrxG complex subunits (Additional file 1: 
Fig. S7), we found evidence for substantial site speciali-
sation by the various TrxG complexes (Fig.  5d). CFP-
SET1A, Menin and UTX peaks were allocated similarly 
(approximately 5%) to non-CGI TSSs. In CGI TSSs, all 
were present at high but differing proportions: 86% of 
CFP1-SET1A peaks, representing SET1A complexes, 
were allocated to CGI TSSs, compared to 74% of Menin 
peaks, representing MLL1/2 complexes, and 51% of UTX 
peaks, representing MLL3/4 complexes. In our previously 
defined enhancers, we found the opposite, with putative 
enhancers representing 6% of CFP1-SET1A peaks, 9% of 
Menin (MLL1/2) peaks and 15% of UTX (MLL3/4) peaks. 
In other non-TSS sites of colocalised ChIP peaks, where 
our conservative criteria did not detect active chromatin, 
the pattern at enhancers was recapitulated, suggesting 
that many of these sites act as enhancers. Interestingly, 
1409 loci (Additional file  1: Fig. S7) that were external 
to CFP1-SET1A peaks nevertheless harboured UTX, 
RBBP5 and Menin (a member of MLL1/2 complexes). 
Approximately half of these (n = 672) were at TSSs. 
MLL2 is known to deposit H3K4me3 to establish bivalent 
domains [27, 28, 40], and UTX is a demethylase known 
to remove repressive H3K27me3 marks [41]. Finding 
these proteins colocalised is consistent with physical 
interaction of UTX with MLL2 complex, a phenomenon 
postulated from co-immunoprecipitation experiments in 
differentiated cell lines [40]. Taken together, this analy-
sis of regions of high-confidence ChIP signals shows: 
(1) TrxG subunits are bound to the genome mostly as 
(See figure on next page.)
Fig. 5 Distribution of TrxG components in erythroid cells. a The α-globin locus, with shaded areas indicating CGIs (green) and putative regulatory 
regions (blue). ChIP signal names indicated to left. Pileups are shown scaled to 1x genome coverage, with full scale 0–50 × depth. b Heatmaps 
showing normalised/input-subtracted erythroid signals for CFP1 and other TrxG subunits. ChIP indicated directly above each heatmap, and TrxG 
complex indicated above that. Upper, TSSs; middle, putative enhancers; and lower, CGIs (ordered by CGI length). c Colocalisation of subunits of 
SET1A methyltransferase complexes in a high-confidence peak-set. Light blue and light red regions represent regions with CFP1 and SET1A peaks, 
respectively. Red outline represents colocalisation between CFP1 and SET1A. Blue outline represents CFP1 peaks colocalised with RBBP5. Number 
in bold represents overlap of all four SET1A complex subunits (CFP1, SET1A, HCF1, and RBBP5). d Specialisation of TrxG complexes for enhancers 
and TSSs. “Other” regions are regions containing peaks of at least two TrxG complex subunits that colocalised neither to TSSs nor putative enhancers 
defined earlier in the study. SET1A/B complexes are represented by CFP1/SET1A, MLL1/2 complexes by MENIN and MLL3/4 by UTX. Note: error bars 
are derived by assuming that similarly prepared ChIP experiments give a number of peaks governed by Poisson statistics
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multi-protein complexes, and it is mostly the presence 
of these complexes that gives rise to the observed ChIP 
signals; (2) although components of all TrxG complexes 
may be found at TSSs, CFP1-SET1A complexes are spe-
cialised to TSSs relative to other TrxG complexes; and (3) 
TrxG complex subunits whose functions include estab-
lishment of H3K4me3 at bivalent domains and clearing 
of the repressive H3K27me3 mark are recruited to sites 
that do not include CFP1.
CFP1 occupancy is associated with specific (epi)genomic 
features and sequence motifs
Given the specificity with which CFP1/SET1A complexes 
bind in the genome, we next asked what sequence-level 
determinants might account for this. Therefore, CFP1 
peaks were analysed for motif enrichment using homer 
[42], and ten optimised motifs, five from CGI-associated 
CFP1 peaks and five from non-CGI peaks, were identified 
(Additional file 1: Table S3, see “Methods”). Four of five 
motifs derived from non-CGI peaks lacked a CpG dinu-
cleotide, and four of these five motifs were also strongly 
biased or exclusive for either cell type, whereas the fifth 
was of low complexity (Additional file 1: Table S3); these 
results demonstrate that CFP1 is binding in a cell type-
specific manner in non-CGI regions. On the other hand, 
all five motifs optimised in CGI-associated CFP1 peaks 
contained a CpG dinucleotide and were found at high 
frequency in CFP1 peak-sets in both EBV and ERY cell 
types (Additional file  1: Table  S3). Genome-wide how-
ever, an average of only 4% of these five CGI-associated 
motifs (ranging from 2.9 to 6.4%) fell within CGIs, simi-
lar to the genomic fraction of CpGs (7.0%) falling within 
CGIs. This result emphasises the known importance of 
the CpG dinucleotide, which is bound by CFP1 through 
its ZF-CxxC domain [17].
To develop a global model of the features specifying 
CFP1 genomic occupancy, we then analysed the cor-
relation of CFP1 ChIP signal with a number of genomic 
signals in addition to genomic CpG density in eryth-
roid cells. We considered: (1) that CFP1 is also known 
to bind all methylation states of H3K4 through its PHD 
finger domain [26, 33]; (2) that SET1 proteins have been 
shown to enhance CFP1 interactions with DNA [17]; and 
(3) that HCF1 and RBBP5 are additional subunits of this 
complex [12, 36]. These ChIP intensities and CpG den-
sity were averaged in 2-kb windows centred on TSSs and 
putative enhancers (Figs.  1a, 4 and 5; n = 41,167 non-
redundant loci). To test the sufficiency of these features 
to explain CFP1 binding, we computed the correlation 
of each feature with CFP1 individually (Additional file 1: 
Table  S4). Across all 41,167 TSSs and enhancers (irre-
spective of chromatin state), all features except H3K4me1 
were correlated with the CFP1 signal (Pearson R2 > 0.1, 
Additional file 1: Table S4). However, restricting our cal-
culations to TSSs and enhancers having top 10% chroma-
tin accessibility scores (4117 sites, Additional file 1: Fig. 
S8, see “Methods”), only three features were still highly 
correlated with the CFP1 signal: H3K4me3, SET1A and 
CpG density. Individually, these features could explain 
28.6, 16.0 and 15.2% of the CFP1 signal, respectively, but 
incorporated in a linear regression model, these features 
accounted for 47.7% of CFP1 signal (Additional file  1: 
Table S5, Additional file 1: Fig. S9). This result shows that 
these three features contribute mostly additively to CFP1 
binding in accessible chromatin regions.
Discussion
Previous studies have demonstrated a key role for CFP1 
in the differentiation of mouse ES cells [22], murine early 
development [21] and haematopoiesis in mouse and fish 
[23–25]. Ablation of CFP1 reduces H3K4me3 at CGIs, 
especially downstream of the TSS, with only moderate 
changes in gene expression [15, 17]. Nevertheless, CFP1 
lacking DNA-binding properties can target regions with 
pre-existing low levels of H3K4me3 [15]. Interaction of 
CFP1 with H3K4me3 occurs via its PHD domain [17, 
26]. Here we have studied the genome-wide occupancy 
of CFP1 in two human haematopoietic lineages. In agree-
ment with a recent genome-wide study in mouse ES cells 
[17], we found CFP1 associated with transcription from 
CGI promoters in human haematopoietic lineages, with 
CFP1 prominently occupying TSSs of both housekeeping 
and tissue-specific genes.
Several features have been found to be correlated with 
CFP1 binding to DNA or chromatin. Some of the earlier 
analyses pointed to the ZF-CXXC domain and its role in 
binding to CpG dinucleotides [14, 16, 43]. A more recent 
study has shown a role for SET1A and methylated H3K4 
in addition to unmethylated CpGs [17]. Our analysis of 
these and other (epi)genomic features found that CpG 
density, H3K4me3 intensity and SET1A intensity were 
the most prominently correlated with CFP1 occupancy 
and are sufficient to explain approximately 48% of CFP1 
binding in open chromatin. This result is particularly 
compelling in view of expected variability in ChIP-seq 
signals and implies that CFP1 genomic occupancy is 
largely determined by: (1) binding of its ZF-CxxC domain 
to CpG dinucleotides; (2) interaction of its PHD finger 
domain with methylated forms of H3K4; and (3) stabilisa-
tion of binding by interaction with SET1. This multifac-
eted model of CFP1 binding may explain the association 
of CFP1 with expression in both the α- and β-globin 
TSSs, which differ strongly in CpG density. In agree-
ment with the observations of others [35], this model 
can explain the tight association we found between ChIP 
peaks of SET1A/B complex members in high-confidence 
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regions of strong CFP1, SET1A, HCF1, Menin, UTX or 
RBBP5 ChIP peaks.
Focusing on enhancers, we found specific occupancy of 
CFP1 at enhancers in both cell types together with posi-
tive correlation with chromatin accessibility. Moreover, 
enrichment of SET1A and its strong correlation with 
CFP1, including at enhancers, support the stabilisa-
tion of CFP1 at enhancers. SET1A is known to interact 
with CFP1 and immobilise CFP1 to DNA [17]. Weaker 
correlation between CFP1 and chromatin accessibil-
ity in enhancers compared to TSSs could be explained 
by reduced affinity of CFP1 for H3K4me1 compared 
with H3K4me3 [17, 33] and depletion of CGIs in most 
enhancers.
In addition to the understanding of the mechanisms by 
which CFP1-containing complexes bind to open chro-
matin in steady state, an enduring question is how tran-
scription is dynamically regulated in a cell type-specific 
manner. Early genome-wide studies showed monovalent 
H3K27me3 is a mark of PcG binding at TSSs and is asso-
ciated with silencing, whereas monovalent H3K4me3 at 
TSSs is associated with high expression in mouse ES cells. 
However, TSSs of genes poised for expression are found 
in an intermediate bivalent (H3K27me3/H3K4me3) state, 
which arises as a result of targeted H3K4 methyltrans-
ferase activity [44–49]. Mutual exclusivity of repressive 
H3K27me3 and CFP1 genome-wide, as reported here, 
thus rules out CFP1-SET1 as the methyltransferase com-
plex responsible for the transition of TSSs from repressed 
to bivalent. Instead, recent evidence shows that MLL2 
methyltransferase activity is required for initial tri-
methylation establishing bivalent promoters in ES cells, 
whereas MLL1 is at least in part redundant [27, 28].
In differentiated cells, CFP1-SET1 complexes have 
been found by others to be responsible for most of the 
H3K4me3 deposition at CGI [16]. In that light, it is inter-
esting that we observed colocalisation between CFP1-
SET1A and Menin (a component of MLL2 complex). 
Perhaps even more enlightening is our observation of 
substantial colocalisation between Menin, RBBP5 (a 
component of all TrxG complexes) and UTX, suggesting 
the possibility of frequent co-recruitment of MLL2 and 
UTX at promoters and enhancers lacking CFP1-SET1A. 
Recent evidence also suggests the existence of a complex 
involving MLL2 and UTX [40]. UTX is an H3K27me3 
demethylase at target genes [41, 50, 51] and at poised 
enhancers as part of MLL3/4 complexes [35, 40, 52] and 
also as a chromatin-remodelling factor [53]. Accordingly, 
our results suggest that before formation of CFP1-SET1 
complexes at TSSs, UTX is recruited together with MLL2 
to remove repressive H3K27me3 and deposit initial 
H3K4me3 [27, 28]. This initial deposition of H3K4me3 by 
MLL2 complexes could provide an anchor for subsequent 
binding of CFP1-SET1 complexes, which may colocalise 
with MLL2 to maintain high levels of H3K4me3, irre-
spective of CpG content. This model presents a coher-
ent explanation for the transition from repressed to open 
chromatin in keeping with our observed mutual exclu-
sivity of the H3K27me3 mark and CFP1 binding. This 
model also places into context the evidence that in dif-
ferentiated cells methyltransferase activity in bivalent 
domains switches from MLL2 to SET1A [54] and thus 
helps to broaden our view of key elements involved in 
gene regulation through chromatin modification. Fur-
ther analyses of mutations in key proteins in this regula-
tory network will be necessary to expand on mechanistic 
insights into CFP1 functions. These might reveal CFP1 
trafficking, protein–protein interactions and their timing, 
and molecular stoichiometry involved in CFP1-depend-
ent gene regulation. Such follow-up studies might also 
address the relationship between genomic CFP1 distri-
bution, genome-wide transcriptional states and RNA 
abundance.
Conclusions
In view of its known specificity for binding to unmeth-
ylated CpG dinucleotides, this study revealed an unex-
pected association of CFP1 with expressed TSSs, even in 
the absence of CGIs. Furthermore, CFP1 was associated 
with Pol II binding at expressed TSSs, regardless of CGI 
status, and this was observed in both cell types. Intrigu-
ingly, in addition to strong occupancy at TSSs, CFP1-
SET1A complexes were also found at other accessible 
chromatin regions, including putative enhancers, which 
were highly enriched in weaker CFP1 peaks. Colocali-
sation of subunits of other TrxG complexes with CFP1-
SET1A complexes was also observed in both TSSs and 
enhancers, though with differential preference, suggest-
ing partial redundancy of TrxG complexes in agreement 
with the observations of others in pluripotent stem cells 
[27].
Methods
Primary cells
Primary erythroid cells and newly generated EBV-
infected B-lymphoblasts were obtained as previously 
described [55]. Public EBV ChIP data sets are from the 
human EBV-infected B lymphocyte cell line GM12878.
ChIP assay
ChIP was performed as previously described [56]. For 
CFP1, HCF1, RbBP5, hSET1 (SETD1A), Menin and 
UTX, chromatin was first cross-linked with ethylene 
glycol bis(succinimidyl succinate) (EGS) [29] in PBS at 
a final concentration of 2 mM for 60 min at RT. Formal-
dehyde  (CH2O) was then added at a final concentration 
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of 1% for 15  min at RT and samples were sonicated 
over 20 min (10 × 30-second episodes) at 4 °C to cleave 
genomic DNA (Bioruptor, Diagenode). Input data sets 
were matched with ChIP-seq samples. Antibodies used 
are: H3K27me3 (07-449) (Millipore); HCF1 (A301-
400A), RbBP5 (A300-109A), hSET1 (SETD1A, A300-
289A), Menin (A300-105A), UTX (A302-374A) from 
Bethyl Labs and CFP1 (CGBP, ab56035) from Abcam. 
The non-commercial CFP1 antibody was kindly pro-
vided by Prof. Robert Roeder. Real-Time PCR was per-
formed using primers and probes (5’FAM-3’TAMRA) 
for the murine and human α-globin locus described 
previously [57, 58]. Each ChIP was performed as two 
independent experiments and quality was assessed by 
qPCR. Libraries and sequencing (ChIP-seq) were per-
formed using the standard Illumina kits and protocols.
DNaseI assay and DNaseI sequencing
Nuclei from human primary erythroid cells were digested 
with increasing concentrations of DNaseI (Roche) as pre-
viously described [59]. DNA (1.5 µg) from the mid-phase 
digestions was blunt-ended with T4 DNA Polymerase 
(NEB) and prepared for Illumina HiSeq 2500 sequencing.
Data sources, protocols and analysis
Sources of ChIP-seq data are shown in Table 1.
ChIP‑Seq analysis
Reads were aligned using the hisat2 aligner version 2.0.3 
with the --no-spliced-alignment option, but otherwise 
default parameters. Reads were aligned to a splicing-una-
ware index of the human GRCh38 genome. ChIP peaks 
were identified using the ENCODE tool Phantompeak-
qualtools [67], an R script that called peaks using the SPP 
library [68] version 1.14. Peaks in each experiment were 
Table 1 Experiments, protocols, read counts and GEO accession numbers
Cell type Data set Crosslinking/Reference Read count (paired) GEO accession
Cell type Data set Crosslinking/Reference Read count (paired) GEO accession
Erythroblasts CFP1 EGS + CH2O 38,713,222 unpaired GSE114084
Erythroblasts CFP1 (Abcam) EGS + CH2O 38,789,474 unpaired GSE114084
Erythroblasts H3K27ac [60] 54,716,349 unpaired GSE70660
Erythroblasts H3K27me3 EGS + CH2O 163,108,458 paired GSE114084
Erythroblasts H3K4me1 [60] 26,492,230 unpaired GSE70660
Erythroblasts H3K4me3 [61] 14,926,093 unpaired GSE36985
Erythroblasts DNase-seq N/A 281,771,876 paired GSE114084
Erythroblasts ATAC-seq [62] 228,886,766 paired GSE74912
Erythroblasts Pol II [61] 106,164,823 unpaired GSE36985
Erythroblasts HCF1 EGS + CH2O 179,476,544 paired GSE114084
Erythroblasts MEN1 EGS + CH2O 81,145,272 paired GSE114084
Erythroblasts RBBP5 EGS + CH2O 90,587,516 paired GSE114084
Erythroblasts SET1A EGS + CH2O 93,079,696 paired GSE114084
Erythroblasts UTX EGS + CH2O 65,366,066 paired GSE114084
Erythroblasts, default input data set Input 1 EGS + CH2O 24,173,450 paired GSE114084
Erythroblasts, matched with HCF1, SET1A Input 2 EGS + CH2O 86,858,360 paired GSE114084
Erythroblasts, matched with MEN1 Input 3 EGS + CH2O 109,489,716 paired GSE114084
EBV-transformed B cells CFP1 EGS + CH2O 39,009,169 unpaired GSE114084
EBV-transformed B cells CFP1 (Abcam) EGS + CH2O 41,374,998 unpaired GSE114084
GM12878 H3K27ac [63] 463,073,456 paired GSE50893
GM12878 H3K27me3 [63] 480,207,766 paired GSE50893
GM12878 H3K4me1 [63] 271,241,104 paired GSE50893
GM12878 H3K4me3 [63] 268,581,398 paired GSE50893
GM12878 DNase-seq [64] 400,610,386 unpaired GSE32970
GM12878 ATAC-seq [65]; first 24 M read pairs in SRA 
data sets SRR3336945-52
192,000,000 paired GSE79921
GM12878 Pol II [66] 60,061,473 unpaired GSE19486
EBV-transformed B cells, default input data set Input 1 EGS + CH2O 19,753,388 paired GSE114084
GM12878, used with H3K27me3 Input 2 [63] 112,326,958 paired GSE50893
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thresholded by FDR < 0.01, except for H3K27me3 in EBV 
cells, in which case peaks were thresholded by FDR < 0.1. 
Narrow peaks were used for analysis of all ChIPs except 
the H3K27me3 mark, in which case region peaks were 
analysed. As a confirmation in specific cases, ChIP peaks 
were secondarily identified using the callpeak function 
of MACS2, version 2.1.1.20,160,309, with narrow peaks 
called using a q-value threshold at 0.01, and broad peaks 
with the --broad-cutoff 0.1 option. Peak colocalisation 
analysis was carried out using the ChIPpeakAnno pack-
age in R, with maximum gap of 1  kb. General genome 
arithmetic, including peak intersection with TSSs, was 
carried out using bedtools [69]. ChIP heatmap plots were 
generated using the bamCompare, computeMatrix and 
plotHeatmap functions of deepTools version 2.5.4 [70]. 
Read depths were compared between ChIP-seq and input 
data sets using bamCompare with flags --scaleFactors-
Method readCount --ratio subtract --binSize 50 --nor-
malizeTo1x 3100000000 --minMappingQuality 30; this 
normalisation and subtraction was performed on all data 
sets. To compare CpG content signal with ChIP signals, 
numbers of CpG sites were counted in 50-bp windows, 
such that 5 CpG sites was computed as 10% of sites in a 
50-bp window. To analyse correlation of two ChIP signals 
or CpG density and ChIP signals, the given signal distri-
butions were first averaged within 2-kb loci and correla-
tion was computed among loci.
Identification of a set of putative enhancers
Putative genomic enhancers were identified by a step-
wise procedure using Assay for Transposase-Accessible 
Chromatin (ATAC), Pol II and H3K4me1 signals. First, 
normalised genome-wide signals for each ChIP were 
constructed by normalising each pileup to 1x genome 
coverage, and subtracting similarly normalised input data 
using the deepTools bamCompare program as described 
above. Genomic regions > 2  kb from gene TSSs exhibit-
ing ATAC-seq signal value > 10 that also exhibited a Pol 
II signal value > 5 were accepted as putative enhancers 
and confirmed by plotting heatmaps of H3K4me1 and 
H3K27ac around these loci.
RNA‑seq analysis and identification of housekeeping 
and cell type‑specific genes
RNA-seq data from NCBI GEO (accession GSE74246, 
three erythroblast samples, and GSE88627, four 
GM12878 EBV-lymphoblast samples) were aligned to 
a special purpose, splice-aware version of the GRCh38 
human genome downloaded from the hisat2 web page 
(https ://ccb.jhu.edu/softw are/hisat 2/index .shtml ). The 
hisat2 aligner, version 2.0.5, was used with default param-
eters. Analysis of expression was performed in R: read 
counts for each locus were obtained in unpaired mode 
using the featureCounts function from the Rsubread 
package, and reads per kilobase of transcript per million 
mapped reads (RPKM) values were calculated using the 
rpkm function from the edgeR package.
Housekeeping genes and candidate tissue-specific 
genes were identified from processed RNA-seq expres-
sion data (16 tissues) warehoused by the EBI Illumina 
body map resource (NCBI GEO accession GSE30611). 
Gene RPKM values were downloaded and thresholded 
at 0.1. A previously reported method [71] developed 
for identification of housekeeping exons was applied 
to whole genes to identify a list of housekeeping genes. 
Briefly, genes with RPKM ≥ 0.1 in all tissues, standard 
deviation in  log2(RPKM) < 1, and no tissue with absolute 
 log2(RPKM/mean(RPKM)) > 2 (all expression ratios less 
than 4 in either direction) were termed housekeeping 
genes. Genes for which either all expression RPKM ≤ 0.1 
or for which more than half of the tissues had RPKM 
values ≤ 10% maximum were considered to be normally 
non-expressed. The maximal expression RPKM value of 
these candidate tissue-specific genes was compared to 
expression RPKM values (averaged across samples) from 
the analysis of erythroid and lymphoid cell types (above). 
If a gene was on the list of normally non-expressed genes 
and its RPKM expression value in erythroid or lymphoid 
tissue was at least half of this maximum, it was termed 
tissue-specific in that tissue.
Analysis of TrxG subunit occupancy in a high‑confidence 
subset of peak regions
To analyse which subunits of TrxG-related methyltrans-
ferase complexes colocalised, we compared six ChIP 
data sets in erythroid cells: CFP1 and SET1A, subunits 
of SET1A/B complexes; HCF1, a subunit of SET1A/B 
and MLL1/2 complexes; Menin, a subunit of MLL1/2 
complexes; UTX, a subunit of MLL3/4 complexes; and 
RBBP5, a core subunit of all the complexes. A high-confi-
dence set of peaks in each data set was defined as its most 
highly enriched tenth percentile, as detected by SPP. Bed-
tools was used to merge these regions into a non-redun-
dant set of high-confidence peak regions. Subsequently 
peaks of all strengths detected by SPP were analysed for 
the presence or absence in these high-confidence regions.
Analysis of motifs in ChIP‑enriched regions
ChIP-enriched regions, identified as peaks by SPP, were 
analysed for motif enrichment using the homer program 
[42]. For each ChIP experiment, peaks were divided into 
two groups by the presence or absence of CGIs. The top 
1000 peaks by coverage depth were analysed in each 
group. Homer selected genomic background sequences 
matched to target sequences by length and 3-bp oligo 
content. Homer then used binomial statistics to compare 
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motif frequencies in target and background sequences. 
It first identified enrichments of 364 known motifs, then 
identified 75 additional de novo motifs (25 each at sizes 
of 8, 10 and 12 base pairs). Thus, a total of 300 partially 
redundant motifs were identified, 150 from CGI-asso-
ciated CFP1 peaks in both cell types and 150 from non-
CGI peaks.
Motifs passing a detection threshold of p < 10−20 were 
selected and further optimised by homer, with optimisa-
tion carried out separately for CGI and non-CGI peaks. 
Target sequences used for the optimisation step were 
combined peaks from ERY and EBV cell types, but with 
redundant peaks removed. The optimised motifs were 
clustered by homer and the most significant exemplar in 
each cluster was reported. The top ten exemplar motifs, 
five identified from CGI-associated CFP1 peaks and five 
from non-CGI peaks, were subsequently detected in CGI 
and non-CGI peaks, respectively. The purpose of this 
detection was to determine if a given motif, which had 
been optimised using sequences from both ERY and EBV 
cells, was biased for ERY or EBV cells; this might occur 
if the motif reflected genes expressed in that cell type 
rather than structural binding preference of CFP1.
Analysis of correlation of ChIP signal intensities with (epi)
genomic features
We sought to understand the relationship between the 
intensity of ChIP and other signals, which might indicate 
functional interaction. CpG density and erythroid ChIP 
signals from CFP1, SET1A, HCF1, RBBP5, H3K4me3, 
H3K4me1, H3K27me3, DNase-seq and ATAC-seq were 
analysed, and ChIP signals were 1x-normalised and input 
was subtracted, as described above. Given that normal-
ised and input-subtracted ChIP signals were noisy, each 
ChIP signal was averaged in a 2-kb region surrounding 
each TSS and putative enhancer to give a robust rep-
resentation of the signal strength. The rare case where 
robust but non-overlapping ChIP-seq peaks are present 
at the same locus in different ChIP experiments, which 
would give a spurious apparent colocalisation, was 
ignored in this analysis. Relative chromatin accessibility 
was estimated from DNase-seq and ATAC-seq signals. 
Given that these signals give differing representations of 
chromatin accessibility, they were combined; first these 
signals were linearly scaled by the z-score transforma-
tion, and then they were averaged. The resulting chroma-
tin accessibility score was therefore more robust and gave 
equal weight to DNase-seq and ATAC-seq data.
Tests of Pearson’s product moment correlation (R2) 
were performed between CFP1 and CpG density, SET1A, 
HCF1, RBBP5, H3K4me1, H3K4me3 and chromatin 
accessibility; this was done in all loci and in a subset of 
loci with upper decile chromatin accessibility scores. 
Features whose correlation R2 value was greater than 10% 
were identified. To test the sufficiency of these features 
to explain CFP1 occupancy in open chromatin, a linear 
regression analysis was performed, and this analysis was 
limited to the top-decile accessible regions.
Additional file
Additional file 1. Fig. S1: Analysis of CFP1 binding at individual loci and 
CpG islands (CGIs). (A‑B) Analysis of CFP1 binding at the human α-globin 
locus in expressing and non-expressing cells. (A) Real-Time PCR analysis 
of immunoprecipitated chromatin using CFP1 antibody in human eryth-
roblasts (red) and B-lymphocytes (blue). The y-axis represents enrichment 
over the input DNA, normalised to a control sequence in the human 18S 
gene. The x-axis represents the positions of Taqman probes used. The cod-
ing sequence is represented by the three exons (Promoter/Ex1, Ex2, Ex3) 
of the α-globin genes. 218 and hBact denote control sequences adjacent 
to the CpG islands of the human LUC7L (218) and ACTB promoters. Error 
bars correspond to ± 1 SD from at least two independent ChIPs. (B) 
Real-Time PCR analysis of immunoprecipitated chromatin using the CFP1 
antibody indicated in humanised erythroblasts (normal, +MCS-R2 (left) 
and mutant, MCS-R2 (right). The y-axis represents enrichment over the 
input DNA, normalised to a control sequence in the mouse GAPDH gene. 
CpG Act denotes additional control sequence at the CGI of the mouse 
ACTB gene. The amplicons highlighted in red represent deleted regions 
in the humanised mice, for which no PCR signal is observed. Error bars 
correspond to ± 1 SD from at least two independent ChIPs. (C) CFP1 ChIP 
signal intensity in the top 200 peaks, by antibody and by cell type. Abcam, 
ab56035 antibody. Roeder, main antibody used in this study. (D) Analysis 
of CGI (green) and non-CGI (blue) transcription start sites (1-kb window, 
centred on TSS). Gene symbols shown with CpG content of individual 
loci in parentheses. Greek letters represent individual globin genes. Fig. 
S2: Peak overlaps of CFP1 and marks of active and repressed chromatin 
in transcription start sites (TSSs). Peaks were detected by MACS2. Venn 
diagrams show that CFP1 peaks within 1-kb of TSSs are strongly associ-
ated with H3K4me3 histone mark and poorly associated with H3K27me3 
repressive histone mark. Cell types are (A) ERY and (B) EBV. Public data 
sets: * NCBI GEO GSE36985, ** NCBI GEO GSE50893. Fig. S3: UCSC tracks 
showing CFP1 and other ChIP signals in gene loci in erythroblasts (ERY) 
and EBV-transformed B-lymphoblasts (EBV). Hg38 coordinates for multiple 
genes, CpG islands (CGI, green boxes), and putative regulatory regions 
(blue boxes) are shown. CFP1 signals are shown in dark reds, inputs in 
grey, histone H3 signals in blues and open chromatin marks in greens. 
All ChIP pileups are scaled to 1x coverage genome-wide and shown in 
a range 0–50, except CFP1 (Roeder) is shown with extended range and 
H3K27me3 graphs scaled by 2x. (A) Tissue-specific binding of CFP1 to 
CGI promoters of tissue-specifically expressed genes. Left (chr16), CGI 
promoters of active genes in alpha globin locus are CFP1-bound in ERY, 
and unbound in EBV. Flanking regions are included, with known tissue-
specific enhancers. Right (chr6), first seven exons of IRF4 locus, active in 
EBV and inactive in ERY, with CFP1 binding to CGI promoter in EBV only. 
(B) CGI promoters of housekeeping genes are CFP1 bound and unmarked 
by H3K27me3. Left (chr7), ACTB locus. Right (chr16), LUC7L locus. (C) CGI 
promoter of RHBDF1 locus (chr16) has H3K27me3 mark and the absence 
of CFP1 binding in both ERY and EBV. Fig. S4: Western blot analysis of 
CGBP (CFP1) expression in mouse and human erythroid and human 
lymphoid cell types. Whole cell extracts (20 µg) were loaded in each lane 
(1) mouse ES, (2) U-MEL, (3) I-MEL, (4) mouse primary erythroblasts and (5) 
human primary T lymphocytes and (6) human primary erythroblasts and 
separated on a 10% SDS-polyacrylamide gel. CFP1 antibody was used at 
a 1:1000 dilution. Fig. S5: Similar cell type-specific CFP1 read depth at CGI 
TSS of HBA1 gene and non-CGI TSS of HBB gene. Upper two tracks use 
the main antibody, and second two tracks use the commercial antibody. 
Coordinates are from the hg38 human genome build. Read depths are 
averaged in 50 bp bins and normalised to 1x genome-wide coverage. 
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Blue boxes, known regulatory regions; green box, CGI. Fig. S6: Distribu-
tion of TrxG components in erythroid cells. Green indicates CGI and blue 
indicates other putative regulatory regions. All loci transcribed right to left. 
Pileups are shown scaled to 1x genome coverage, with full scale 0–50x 
depth. (A) Housekeeping genes ACTB, left (chr7), and LUC7L, right (chr16). 
(B) β-globin locus (chr11), (C) Non-expressed RHBDF1 locus (chr16). Fig. 
S7: Overlap of TrxG subunit ChIP peaks in a high-confidence subset of 
regions. SET1A complexes are represented by CFP1-SET1A colocalisation. 
MLL1/2 complexes are represented by Menin, and MLL3/4 complexes 
are represented by UTX, respectively. HCF1 is found in SET1A/B and 
MLL1/2 complexes, and RBBP5 is a member of SET1A/B and MLL1/2/3/4 
complexes. Red outline (4220 peaks) shows strong colocalisation of 
Menin and CFP1-SET1A, accounting for the vast majority (99.5%) of 4242 
CFP1-SET1A and half (50.0%) of 8432 Menin peak regions. Majority (87.0%, 
2089/2400 peaks) of HCF1 (blue region) is accounted for by approximately 
half (49.5%, 2089/4220) of regions of Menin-SET1A-CFP1 colocalisation. 
Regions where either SET1A-CFP1 or Menin or both are colocalised with 
HCF1 (blue dashed line) accounts for nearly all (99.6%, 2390/2400) HCF1 
regions, suggesting that HCF1 bound to DNA is primarily present as part 
of SET1A/B or MLL1/2 complexes. Fig. S8: Chromatin accessibility in TSSs 
and enhancers in erythroid cells as measured by ATAC-seq and DNase-
seq. 1x-normalised, input-subtracted signals from ATAC-seq and DNase 
were averaged in a 2-kb window about TSSs and putative enhancers. 
Z-score transformed values for ATAC-seq and DNase-seq at a given locus 
were averaged. Fig. S9: Relationship of CFP1 signal to three predictive 
factors in top-decile open chromatin regions. A linear combination of CpG 
density and SET1A and H3K4me3 ChIP signals explains a substantial frac-
tion of variation in CFP1 ChIP signal. Table S1: Bias of CFP1 for CGI TSSs in 
cell types and gene classes. Table S2: Bias of CFP1 for housekeeping gene 
TSSs. Table S3: Motifs associated with CFP1 peaks. Table S4: Dependence 
of CFP1 ChIP signal in erythroid cells on covariates putatively associated 
with its binding. Table S5: Analysis of variance of CFP1 signal in top-decile 
open chromatin regions surrounding TSSs and putative enhancers.
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